| scholarly article | Q13442814 |
| P50 | author | C. Blake Gilks | Q90823350 |
| P2093 | author name string | David G Huntsman | |
| Y Z Wang | |||
| Dianne M Miller | |||
| Hui Xue | |||
| Jessica N McAlpine | |||
| Alessandro De Luca | |||
| Melinda A Miller | |||
| Joshua Z Press | |||
| Jennifer A Kenyon | |||
| P2860 | cites work | Significance analysis of microarrays applied to the ionizing radiation response | Q24606608 |
| Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy | Q27860519 | ||
| Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase | Q28131711 | ||
| Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities | Q33315604 | ||
| Cancer of the ovary | Q34375262 | ||
| Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy | Q35150629 | ||
| Morphological effects of chemotherapy on ovarian carcinoma | Q35585946 | ||
| Targeting the DNA repair defect of BRCA tumours | Q36162913 | ||
| Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation | Q42497877 | ||
| Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase | Q43839560 | ||
| Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily. | Q44135089 | ||
| The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation. | Q44907854 | ||
| Mouse models of gynecologic pathology | Q46510692 | ||
| Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance | Q50626711 | ||
| Human Tumor Xenografts as Predictive Preclinical Models for Anticancer Drug Activity in Humans: Better than Commonly Perceived—But They Can Be Improved | Q56865079 | ||
| Gene Expression Profiles of Serous, Endometrioid, and Clear Cell Subtypes of Ovarian and Endometrial Cancer | Q62112715 | ||
| Clinicopathologic features of BRCA-linked and sporadic ovarian cancer | Q73782102 | ||
| Histopathologic assessment of tumor regression after neoadjuvant chemotherapy in advanced-stage ovarian cancer | Q80070141 | ||
| Histopathologic assessment of chemotherapy effects in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking | Q80300655 | ||
| Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models | Q81120942 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cytotoxicity | Q246181 |
| chemotherapy | Q974135 | ||
| xenograft | Q64148587 | ||
| P304 | page(s) | 256-264 | |
| P577 | publication date | 2008-06-10 | |
| P1433 | published in | Gynecologic Oncology | Q5625182 |
| P1476 | title | Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy | |
| P478 | volume | 110 |
| Q30839218 | A class of extracellular vesicles from breast cancer cells activates VEGF receptors and tumour angiogenesis. |
| Q36123789 | Biobanking of patient and patient-derived xenograft ovarian tumour tissue: efficient preservation with low and high fetal calf serum based methods |
| Q35592388 | Conventional chemotherapy and oncogenic pathway targeting in ovarian carcinosarcoma using a patient-derived tumorgraft |
| Q64969004 | Current Status of Patient-Derived Ovarian Cancer Models. |
| Q50938903 | Establishment and characterization of uterine sarcoma and carcinosarcoma patient-derived xenograft models. |
| Q39176960 | Establishment of a novel experimental model of human angiosarcoma and a VEGF-targeting therapeutic experiment |
| Q34776859 | Establishment of human patient-derived endometrial cancer xenografts in NOD scid gamma mice for the study of invasion and metastasis |
| Q64101398 | Gene expression differences between matched pairs of ovarian cancer patient tumors and patient-derived xenografts |
| Q37272622 | Histologic and molecular analysis of patient derived xenografts of high-grade serous ovarian carcinoma |
| Q98777898 | Human-Derived Model Systems in Gynecological Cancer Research |
| Q28742873 | Identification of novel therapeutic targets in microdissected clear cell ovarian cancers |
| Q38221430 | Imaging preclinical tumour models: improving translational power |
| Q47825939 | Intravital biobank and personalized cancer therapy: the correlation with omics. |
| Q26786724 | Molecular and clinical implementations of ovarian cancer mouse avatar models |
| Q35448716 | Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts |
| Q21195204 | Molecular profiling of patient-derived breast cancer xenografts |
| Q39673894 | Next generation patient-derived prostate cancer xenograft models |
| Q38508812 | Ovarian and cervical cancer patient derived xenografts: The past, present, and future. |
| Q38722976 | Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies. |
| Q34125001 | Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review |
| Q34141193 | Patient-derived xenograft models in gynecologic malignancies |
| Q26829125 | Patient-derived xenograft models to improve targeted therapy in epithelial ovarian cancer treatment |
| Q92462041 | Patient-derived xenografts of different grade gliomas retain the heterogeneous histological and genetic features of human gliomas |
| Q38317188 | Patient-derived xenografts recapitulate molecular features of human uveal melanomas |
| Q41533087 | Prognostic relevance of a T-type calcium channels gene signature in solid tumours: A correlation ready for clinical validation |
| Q33898564 | Stability of preclinical models of aggressive renal cell carcinomas |
| Q52799875 | The allosteric AKT inhibitor, MK2206, decreases tumor growth and invasion in patient derived xenografts of endometrial cancer |
| Q24630783 | Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes |
| Q37626455 | Tumorgrafts as in vivo surrogates for women with ovarian cancer. |
| Q30409503 | Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer |
Search more.